#Selinexor in combination with #Ruxolitinib achieved a statistically significant improvement in spleen volume reduction for patients with #Myelofibrosis, according to results of the phase 3 SENTRY trial, via selinexor’s developer, Kayopharm Therapeutics
Read more: https://bit.ly/4sokWB9
🩸Final Questions on Myelofibrosis! Swipe to see the answers and their explanations.
Stay tuned for our next question series on Chronic Myelomonocytic Leukemia (CMML)!
#Myelofibrosis #MF #HemeHub #Hematology #HemOnc #MyeloidNeoplasms #BoneMarrowFibrosis #Anemia #Momelotinib #BloodDisorders #HEMEHUB
🩸Today’s questions!
Swipe to see the answers and their explanations.
#Hematology #ClinicalHematology #Myelofibrosis #PolycythemiaVera #MyeloproliferativeNeoplasms #MPN #PostPVMF #BoneMarrowDisorders #Splenomegaly #Leucoerythroblastosis #HemeOnc #MedEd #HemeHub #ACVR1 #ALK2
🩸🩺Today’s questions!
Swipe to see the answers and their explanations!
#Myelofibrosis #MF #JAK2 #CALR #MPL #Hematology #BloodCancer #StemCellTransplant #HemeOncology #Momelotinib #Ruxolitinib #SIMPLIFY1Trial #SVR35 #ClinicalTrials #PatientCare #BloodDisorders
🩸Additional facts about transplantation & curative intent in Myelofibrosis
#Myelofibrosis #MF #Hematology #Spleen #BloodCancer #JAKInhibitors #Engraftment #AML #Hematopoiesis #BoneMarrowFibrosis #PatientCare #BloodDisorders #MedEd #HEMEHUB
🩸🩺Today’s questions!
Swipe to see the answers and their explanations!
#Myelofibrosis #MDS #Hematology #MedEd #BloodDisorders #Luspatercept #Imetelstat #Navtemadlin #Pelabresib #Anemia #HEMEHUB
🩸Facts about Myelofibrosis:
Transplantation & Curative Intent
#Myelofibrosis #MF #Hematology #StemCellTransplant #AlloHSCT #BoneMarrowTransplant #BloodDisorders #JAK2 #CALR #MPL #TransplantMedicine #RIC #MedEd #HEMEHUB
🩸🔍Today’s question!
Swipe to see the answer and its explanation!
#Hematology #Myelofibrosis #MPN #MyeloproliferativeNeoplasms #Ruxolitinib #Immunotherapy #NKCells #CellTherapy #HemOnc #Oncology #BloodDisorders #MedEd #MedicalEducation #HEMEHUB
🩸 Further insights into anemia management strategies in Myelofibrosis
#Hematology #Myelofibrosis #Anemia #MyeloproliferativeNeoplasms #MPN #BloodDisorders #HemOnc #Oncology #MedEd #MedicalEducation #BoneMarrow #IronOverload #Thrombosis #HEMEHUB
New or worsening #Anemia during #Ruxolitinib treatment is linked with worse survival in patients with #Myelofibrosis (MF). Study in Leukemia & Lymphoma.
Read more: https://bit.ly/4rDnCdF
#RareDisease #MedSky
🩸🩺Today’s questions!
The first question focuses on a common adverse event associated with pelabresib.
The second question highlights a promising approach to specifically target mutant CALR.
Swipe to see the answers and their explanations!
#Myelofibrosis #Hematology #Oncology #MPN #MedEd #HEMEHUB
🩸Facts about Myelofibrosis:
Specific Strategies for Anemia
#Myelofibrosis #Hematology #Oncology #BloodDisorders #Anemia #ESAtherapy #Danazol #Thalidomide #Lenalidomide #Hepcidin #Erythropoiesis #MedEd #RareDiseases #HEMEHUB
🩸 Happening next week!
Register: hemehub.org/live-webinars
Submit your cases: hemehub.org/case-submiss...
#Myelofibrosis #MPN #Hematology #BloodCancer #JAKInhibitors #BoneMarrow #Transplantation #HemeHub #BloodDisorders @mayocliniccancer.bsky.social @mayoclinic.org
In the open-label FIBROMET trial, metformin treatment was associated with reductions in bone marrow fibrosis and downregulation of key oncogenic signaling pathways in patients with primary #myelofibrosis.
https://bit.ly/4rzUSlW
🩸🔬Today’s questions!
The first question reviews key features distinguishing "prefibrotic" #PMF from #ET.
The second question focuses on targeted therapy for #anemia in MF.
Swipe to see the answers and their explanations!
#Myelofibrosis #PrefibroticPMF #MPN #Hematology #HemeOnc #MedEd #HemeHub
🩸 Additional insights on combination & emerging therapies in Myelofibrosis
#Myelofibrosis #HemeOnc #Hematology #MedEd #ClinicalTrials #HEMEHUB #Luspatercept #PIM1 #Nuvisertib #TP3654 #Ruxolitinib #Momelotinib #Imetelstat #TregTherapy #Immunotherapy
🩸Today’s questions!
Swipe to see the answers and their explanations.
#Myelofibrosis #MF #Hematology #HemeOnc #HematologyEducation #MedEd #MedicalEducation #ClinicalTrials #JAKInhibitors #Momelotinib #Ruxolitinib #SIMPLIFY1 #ASH #HemeHub @ash.edu.hematology.org @ash.hematology.org
🩸Facts about Myelofibrosis:
Combination & Emerging Therapies
#Myelofibrosis #HemeOnc #Hematology #MedEd #ClinicalTrials #Epigenetics #Pelabresib #Ruxolitinib #JAKInhibitors #Selinexor #NFkB #Cytokines #HemeHub #HematologyEducation #MedicalEducation
🩸 Happening next week!
🔗Register: hemehub.org/live-webinars
💬Case submissions: hemehub.org/case-submiss...
#Myelofibrosis #MPN #Hematology #BloodCancer #JAKInhibitors #BoneMarrow #Transplantation #HemeHub #PatientCare #MedicalEducation #BloodDisorders @mayocliniccancer.bsky.social @mayoclinic.org
🩸🔬Today’s question!
Swipe to see the answer and its explanation!
#Myelofibrosis #MF #Hematology #HemeOnc #Hepcidin #JAKSTAT #Erythropoiesis #MPN #BloodDisorders #HematologyEducation #MedEd #HemeHub #ClinicalHematology #PatientCare @gmpnsf.bsky.social
🩸 Additional insights on JAK inhibitor therapy in myelofibrosis
#Myelofibrosis #MF #Hematology #HemeOnc #JAKInhibitors #Momelotinib #Ruxolitinib #Fedratinib #Pacritinib #Thrombocytopenia #Platelets #JAKiDiscontinuation #ClinicalTrials #SIMPLIFY2Trial #MedEd #BloodDisorders #MPN #HEMEHUB
🩸 Join our upcoming session on myelofibrosis featuring insights from Ayalew Tefferi, MD, and Taha Bat, MD!
🔗Register: hemehub.org/live-webinars
💬Submit your cases: hemehub.org/case-submiss...
#Myelofibrosis #MPN #Hematology #BoneMarrow #Transplantation #HemeHub @mayocliniccancer.bsky.social
MPN24, a #hematopoietic stem and progenitor cell-derived 24-gene weighted-sum expression score, was found to be prognostic of survival in #myelofibrosis, with a worse five-year OS observed in high-scoring patients versus low-scoring patients: https://ow.ly/KwNm50YpMLz
#HemeSky #MedSky
🩸Today’s questions!
Swipe to see the answers and their explanations!
#Myelofibrosis #MPN #Hematology #HemeOnc #Ruxolitinib #Selinexor #Pelabresib #JAKInhibitors #Hepcidin #Erythropoiesis #Splenomegaly #BoneMarrow #BloodDisorders #MedEd #ClinicalHematology #MPNResearch #BloodCancer #HEMEHUB
🩸Facts about Myelofibrosis:
JAK Inhibitor Therapy
#Myelofibrosis #MPN #Hematology #JAKInhibitors #Ruxolitinib #Momelotinib #ACVR1 #Hepcidin #Erythropoiesis #Splenomegaly #BoneMarrow #BloodDisorders #ClinicalHematology #MedEd #HemeOnc #HEMEHUB
@gmpnsf.bsky.social @rarediseaseadvisor.bsky.social
🩸 Don’t miss our upcoming session on myelofibrosis featuring Ayalew Tefferi, MD, and Taha Bat, MD!
🔗Register: hemehub.org/live-webinars
💬Submit your cases: hemehub.org/case-submiss...
#Myelofibrosis #MPN #Hematology #JAKInhibitors #BoneMarrow #HemeHub @mayocliniccancer.bsky.social @mayoclinic.org
🩸Today’s question focuses on managing anemia in a patient with myelofibrosis who develops transfusion dependence during treatment.
See the answer and explanation on the next slide!
#Myelofibrosis #PMF #MPN #Hematology #HemeOnc #Ruxolitinib #Momelotinib #Anemia #MedEd #MedicalEducation #HemeHub
🩸Additional insights into disease pathogenesis and diagnosis in Myelofibrosis
#Myelofibrosis #PrimaryMyelofibrosis #Hematology #MPN #HemeOnc #MedEd #BoneMarrow #Anemia #Neutrophils #BloodDisorders #HemeTwitter #HemeHub
@mpnjournal.bsky.social @gmpnsf.bsky.social @rarediseaseadvisor.bsky.social
🩸Happening in 3 weeks!
➡️Register: hemehub.org/live-webinars
➡️Submit your cases: hemehub.org/case-submiss...
#Myelofibrosis #MPN #Hematology #HemeHub
@mayocliniccancer.bsky.social @mayoclinic.org @rarediseaseadvisor.bsky.social @gmpnsf.bsky.social
@mpnjournal.bsky.social @bsochaem.bsky.social
🩸Today’s question focuses on the clinical impact of ruxolitinib plus pelabresib in newly diagnosed primary myelofibrosis.
See the answer and explanation on the next slide!
#Myelofibrosis #PMF #Hematology #JAK2 #Ruxolitinib #Pelabresib #ClinicalTrials #HemeOnc #MedicalEducation #HemeHub
